灌注系统市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPMD00002293
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 167
Buy Now

2018 年灌注系统市场价值为 10.4475 亿美元,预计 2019 年至 2027 年复合年增长率为 3.8%。

灌注是通道液体通过循环系统或淋巴系统到达器官或组织,通常指将血液输送到组织中的毛细血管床。灌注测量为血液输送到组织的速率,或每单位组织质量每单位时间的血液量(血流量)。在大型手术期间,灌注必须由相关医疗专业人员维持和管理,而不是仅仅依靠身体的稳态。灌注系统市场的增长归因于心血管疾病患病率的上升、制药和生物技术行业的显着增长、器官移植需求的不断增长以及基于细胞的研究活动的增加在灌注系统市场的增长中发挥着至关重要的作用。然而,昂贵的器官移植手术和器官移植手术捐献者数量有限等挑战可能会影响预测期内市场的增长。另一方面,新兴国家的技术发展为未来几年的市场增长提供了重大机遇。

灌注系统市场预计在大流行后将出现大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

利润丰厚的地区灌注系统市场


市场洞察

灌注系统在医疗保健中的不断增长的应用将推动灌注系统市场的增长

心血管疾病(CVD) 是心脏和血管疾病,包括脑血管疾病、冠心病、风湿性心脏病和其他疾病。导致死亡和困难的一些主要因素是吸烟、不健康的饮食和缺乏运动,这些都会增加心脏病发作和中风的风险。心血管疾病是全球主要死亡原因,与任何其他疾病相比,它影响的人数更多。除了生活方式和习惯外,老年人更容易患心血管疾病。人口老龄化通常表现出一生中血管积累的结构和功能改变。因此,它会增加患心血管疾病的风险。

全世界心血管疾病的患病率正在增加。导致人群心血管疾病发生的关键因素。心血管疾病是全世界死亡的主要原因。据美国心脏病学会称,CVD 在美国造成近 80 万人死亡,约占死亡人数的三分之一。冠心病 (CHD) 是大多数 CVD 死亡的原因,其次是中风和心力衰竭。近超过 9000 万美国人被诊断患有 CVD。此外,据称,在全球范围内,心血管疾病约占所有死亡的 31%,预计到 2030 年,心血管疾病的费用将约为 10,440 亿美元。

在欧洲,心血管疾病 (CVD) 每年导致 390 万人死亡,其中欧盟 (EU) 死亡人数超过 180 万人。 CVD 占欧洲所有死亡人数的 45.0%,占欧盟所有死亡人数的 37.0%。 CVD是所有国家男性和女性死亡的主要原因。因此,在心脏手术过程中,灌注系统需要绕过心脏和肺的功能,帮助维持血液循环和体内的含氧量。因此,由于心血管疾病在各地区和各国的患病率不断上升,在预测期内用于治疗心血管疾病的灌注系统的需求可能会增加市场。

 < /p>

灌注系统市场也受到制药和生物技术行业显着增长的推动。在过去的几年里,制药和生物技术行业以异常快速的速度发展。慢性和急性疾病患病率的上升引起了对药物、治疗剂、疫苗、抗生素等的需求。技术进步帮助制造商轻松提高产量。这些制造商及其与合同研究组织 (CRO) 的联盟正面临着新药物、治疗形式、不断发展的数字化和不断变化的法规带来的巨大医疗保健挑战。此外,老年人口的增加导致医疗保健条件不断恶化。根据世界卫生组织的数据,全球人口每年增加 1.24%,导致老年人口数量增加。

世界卫生组织还建议,65 岁到 65 岁的人口比例80 到 2030 年将上升到 28%,而 2000 年为 22%。此外,根据 Torreya Economical Model 2017 发布的调查报告,到 2017 年,制药行业比之前的估计增长了 30%,并跻身前五名之一。行业增加了全球经济价值。

此外,全球范围内制药、生物制药和生物技术初创公司的数量也在不断增加。这些公司正在开发创新药物和治疗产品,并得到了各国政府的支持。因此,初创企业和老牌企业在药品和其他治疗产品的生产方面呈现出巨大的增长。药物和治疗产品的生产需要灌注系统和灌注系统来生产由生物来源获得的原材料。生物技术公司还从事农业、食品和饮料等行业原材料的生产。与制药行业相比,生物技术公司对灌注系统的要求更高。因此,由于这些因素,灌注系统的市场可能会在未来的预测几年中得到推动。

器官移植是一种外科手术,当患者的身体状况良好时进行。器官已完全停止运作。器官移植通常针对心脏、肝脏和肾脏等器官进行。然而,慢性疾病病例的不断增加导致需要移植其他器官,如肺、胰腺、角膜和血管组织等。器官移植被认为是现代医疗行业最先进的技术之一。

导致心、肺、肝、肾等器官功能损害的慢性疾病的增多,导致器官移植数量的增加。世界各地的器官移植手术正在兴起。例如,西班牙大约进行了5260例移植手术,其中肾移植手术近3200例,肝移植手术约1200例。心脏移植手术数量约300例,肺移植手术近360例。移植协调员协助下的公私合作伙伴关系为器官移植的改善做出了巨大贡献。发展中国家和发达国家的器官移植手术数量都很高。例如,印度和新加坡等发展中国家正在成为亚太地区的医疗旅游目的地。这些国家在提供更好、更先进的医疗方面正在不断发展。

根据 2017 年国家慢性肾脏病情况说明书,估计美国约有 3000 万人患有慢性肾脏病。同样,根据美国国家糖尿病、消化和肾脏疾病研究所的数据,近 661,000 名美国人患有肾衰竭,其中 468,000 名患者正在接受透析,大约 193,000 名患者接受了肾移植。因此,未来几年发病率的增加可能会增加对肾移植的需求。同样,据估计,越来越多的心脏病也将推动未来的市场。因此,器官移植需求的增长是灌注系统市场的关键驱动因素之一。

慢性病的增加,生物技术应用的优势正在开展广泛的基于细胞的研究活动。基于细胞的测定有助于了解生物体的生物学挑战。研究有助于了解疾病过程及其复杂性。基于细胞的检测有助于了解细胞信号传导、增殖、凋亡、细胞遗传学、神经病学、癌症等方面。

基于细胞的检测广泛应用于制药、生物技术行业、研究机构和学术研究机构。制药和生物制药行业需要有效地将药物商业化。因此,制药和生物技术行业中基于细胞的检测是灌注系统发展的驱动因素。

合同研究组织也广泛开展基于细胞的检测,用于临床试验研究和其他过程。癌症等慢性疾病和其他遗传相关研究正在加强基于细胞的研究。例如,Charles River 为人类原代细胞检测提供服务,根据该公司发表的一篇文章指出,基于细胞的检测的发展未来可能会继续增长。它指出基于细胞的测定有助于药物发现,因为体外与体内的相关性在药物开发中起着至关重要的作用。因此,基于细胞的研究活动的增加可能会在预测期内推动灌注系统的发展。

基于类型的见解

就以下方面而言:类型,灌注系统市场分为微流体灌注系统、小型哺乳动物器官灌注系统、生物反应器灌注系统、重力或压力驱动灌注系统。 2018 年,按类型划分,生物反应器灌注系统细分市场占有最大的市场份额,占灌注系统市场的 44.3%。

按类型划分的灌注系统市场 – 2018年和2027年


基于组件的见解

基于组件,市场灌注系统进行细分应用于灌注泵、氧合器、心肺机、监测系统、插管等。制氧机领域预计在预测期内复合年增长率为 4.4%。

战略见解

灌注系统市场参与者正在采用产品推出和扩张战略,以满足全球不断变化的客户需求,这也使他们能够在全球范围内保持其品牌名称。

灌注系统市场 –按类型

  • 微流体灌注系统
  • 小型哺乳动物器官灌注系统
  • 生物反应器灌注系统
  • 重力或压力驱动灌注系统

灌注系统市场 –按组件划分

  • 灌注泵
  • 制氧机
  • 心肺机
  • 监测系统
  • 插管
  • 其他

灌注系统市场 –按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

     

    公司简介

    • REPLIGEN CORPORATION
    • Merck KGaA
    • Ala Scientific Instruments, Inc .
    • XVIVO 灌注
    • 美敦力
    • XENIOS AG(Fresenius Medical Care AG & Co. KGaA)
    • Getinge AB
    • TERUMO CORPORATION
    • LivaNova PLC
    • Sartorius AG
    • 哈佛生物科学
    • RAND
    • Sanisure ( Sani-Tech West, Inc.)
    • AutoMate Scientific, Inc
    • Jobst Technologies GmbH
    • APD(高级灌注诊断)
    • Spectrum医疗、Transonic Systems Inc
    • OrganOx
    • ISCHEMAVIEW, INC
    • CESCO BIOENGINEERING CO., LTD

     < /p>

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Perfusion Systems Market

  1. REPLIGEN CORPORATION
  2. Merck KGaA
  3. Ala Scientific Instruments, Inc.
  4. XVIVO Perfusion
  5. Medtronic
  6. XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  7. TERUMO CORPORATION
  8. Getinge AB
  9. Harvard Bioscience
  10. OrganOx

Emerging Players

  1. Sartorius AG
  2. RAND
  3. LivaNova PLC
  4. Sanisure (Sani-Tech West, Inc.)
  5. AutoMate Scientific, Inc.
  6. APD (Advanced Perfusion Diagnostics)
  7. Spectrum Medical
  8. Transonic Systems Inc
  9. CESCO BIOENGINEERING CO., LTD.
  10. Jobst Technologies GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports